Literature DB >> 26467404

Feasibility and safety of temporary subcutaneous venous figure-of-eight suture to achieve haemostasis after ablation of atrial fibrillation.

Sarah Traullé1, Maciej Kubala2, Alexandre Doucy2, Serge Quenum2, Jean-Sylvain Hermida2.   

Abstract

AIMS: This prospective study was carried out to assess the feasibility and safety of venous figure-of-eight suture to achieve haemostasis after atrial fibrillation (AF) ablation. METHODS AND
RESULTS: Consecutive patients who underwent catheter ablation of AF were prospectively enrolled from February 2012 to September 2013. At the end of the procedure, a temporary subcutaneous 'Figure-of-eight' suture technique was used to achieve haemostasis. Anticoagulation strategy evolved during the study. Initially, vitamin K antagonists (VKAs) were stopped and replaced by administration of low-molecular-weight heparin. It was subsequently decided to perform these procedures without stopping VKA. With the arrival of direct oral anticoagulants (DOACs), it was decided to miss the evening dose before the procedure. One hundred and twenty-four patients were included. Seventy-three per cent of patients were male, and the mean age was 58 ± 10 years old. One hundred and twelve patients (90%) experienced paroxysmal AF and were treated by cryotherapy with the use of a 15 Fr outer diameter Flexcath Advance sheath. The 'Figure-of-eight' suture technique was able to be performed in all patients and was sufficient in 114 patients. Mechanical external compression was required for 10 patients. Three patients developed a haematoma. The overall incidence of haematoma was therefore 2.4%.
CONCLUSION: Figure-of-eight suture is a fast closure technique that can be used as an efficient alternative to usual compression methods to prevent bleeding during high-intensity anticoagulation and the use of large-diameter venous sheaths and multiple femoral venous accesses. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2015. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  Ablation; Atrial fibrillation; Complications; Haematoma; Haemostasis; Suture technique

Mesh:

Substances:

Year:  2015        PMID: 26467404     DOI: 10.1093/europace/euv266

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  5 in total

1.  Risk factors for venous bleeding complication at the femoral puncture site after catheter ablation of atrial fibrillation.

Authors:  Hirofumi Arai; Akira Mizukami; Yoshihiro Hanyu; Takuya Kawakami; Yuki Shimizu; Jiro Hiroki; Kenji Yoshioka; Hirofumi Otani; Shunsuke Kuroda; Ryota Iwatsuka; Daisuke Ueshima; Tatsuya Hayashi; Akihiko Matsumura; Masahiko Goya; Tetsuo Sasano
Journal:  J Arrhythm       Date:  2020-06-01

2.  Prevalence and Characteristics of Venous Thrombosis after Catheter Ablation of Atrial Fibrillation in Patients Receiving Periprocedural Direct Oral Anticoagulants.

Authors:  Takehito Sasaki; Kohki Nakamura; Kentaro Minami; Yutaka Take; Keiko Koyama; Eiji Yamashita; Shigeto Naito
Journal:  J Atr Fibrillation       Date:  2018-12-31

3.  Comparative outcomes of vascular access closure methods following atrial fibrillation/flutter catheter ablation: insights from VAscular Closure for Cardiac Ablation Registry.

Authors:  Moghniuddin Mohammed; Rigoberto Ramirez; Daniel A Steinhaus; Omair K Yousuf; Michael J Giocondo; Brian M Ramza; Alan P Wimmer; Sanjaya K Gupta
Journal:  J Interv Card Electrophysiol       Date:  2021-04-02       Impact factor: 1.759

4.  Femoral venous hemostasis after atrial fibrillation ablation: Is figure-of-eight suture the way to go?

Authors:  Syeda Atiqa Batul; Rakesh Gopinathannair
Journal:  Indian Pacing Electrophysiol J       Date:  2017-08-31

5.  Figure-of-eight suture for venous hemostasis in fully anticoagulated patients after atrial fibrillation catheter ablation.

Authors:  Umashankar Lakshmanadoss; Wai Shun Wong; Ilana Kutinsky; M Rizwan Khalid; Brian Williamson; David E Haines
Journal:  Indian Pacing Electrophysiol J       Date:  2017-02-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.